Skip to main content

APTURA 1 study of tocilizumab biosimilar. Not surprisingly no difference. I'm excited about this product. Hopefully be t

Nov 14, 2023 5:49 pm
Social Author Name
Richard Conway
Tweet Content
APTURA 1 study of tocilizumab biosimilar. Not surprisingly no difference. I'm excited about this product. Hopefully be the end to our tocilizumab supply issues and significant societal savings Abstr#0445 #ACR23 @RheumNow https://t.co/qvP7LCeAkm https://t.co/Zb1FUAlXlz
Show on Archive Page
On
Display in Search Results
On
PDQ
Off
×